Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
BRIEF-Acumen Pharmaceuticals, Inc. Q2 Income From Operations USD -32.556 Million Vs. IBES Estimate USD -24.6 Million

BRIEF-Acumen Pharmaceuticals, Inc. Q2 Income From Operations USD -32.556 Million Vs. IBES Estimate USD -24.6 Million

ReutersReuters2026/08/12 11:01

Aug 12 (Reuters) - Acumen Pharmaceuticals, Inc. Q2 operating expenses USD 32.556 million.

  • Q2 basic EPS USD -0.45
  • Q2 net income USD -32.718 million vs. IBES estimate USD -23.3 million
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!